subject area of
- 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
- A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial Academic Article
- Andexanet alfa for the treatment of hemorrhage Academic Article
- Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward Academic Article
- Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Academic Article
- Antidotes for Novel Oral Anticoagulants Academic Article
- Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial Academic Article
- Central venous access device insertion and perioperative management of patients with severe haemophilia A Academic Article
- Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials Academic Article
- Comparing bleed frequency and factor concentrate use between haemophilia A and B patients Academic Article
- Concentrate‐related inhibitor risk: is a difference always real? Academic Article
- Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption Academic Article
- Current use of biologicals in thrombosis and haemostasis Academic Article
- Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran Academic Article
- Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH Academic Article
- Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation Academic Article
- Factor VIIa gets even bigger Academic Article
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors Academic Article
- Haemophilia clinical care and research needs: Assessing priorities Academic Article
- Haemophilia in a real-world setting: the value of clinical experience in data collection Academic Article
- Identification of the MMRN1 Binding Region within the C2 Domain of Human Factor V Academic Article
- Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study Academic Article
- Inhibitor development in non-severe haemophilia across Europe Academic Article
- Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments Academic Article
- Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more Academic Article
- Low Dose Prophylaxis vis-a-vis on-Demand Treatment Strategies for Hemophilia: A Cost Effective and Disability Attenuating Approach. Academic Article
- Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH Academic Article
- Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate Academic Article
- Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study Academic Article
- Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate Academic Article
- Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants Academic Article
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study Academic Article
- Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH Academic Article
- Responses to Aggregating Agents after Cleavage of GPIb of Human Platelets by the O-Sialoglycoprotein Endoprotease from Pasteurella haemolytica— Potential Surrogates for Bernard-Soulier Platelets? \textbar Request PDF Article
- Reversal agents for non-vitamin K antagonist oral anticoagulants Academic Article
- Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting Academic Article
- Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study Academic Article
- Specific antidotes for bleeding associated with direct oral anticoagulants Academic Article
- Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Academic Article
- Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A Academic Article
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH Academic Article
- Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure Academic Article